Iovance Biotherapeutics
Price & Volume
Stats
See moreOpen | $3.93 |
Previous Close | $3.93 |
Day Range | $3.77-$3.93 |
52W Range | $1.76-$5.63 |
Market Cap | $1.8B |
Shares Short | 100M |
Financials
See moreRevenue (12 Mos) | $285.6M |
Revenue Growth (YoY) | 44.8% |
Gross Profit (12 Mos) | $112.6M |
Diluted EPS | -$0.92 |
News
See moreYahoo Finance • 7 days ago
This Stock Is Up 74% This Year: Is It Too Late to Buy?
Yahoo Finance • 11 days ago
Heartflow vs. Iovance Biotherapeutics: Which Healthcare Stock Is a Better Buy in 2026?
Yahoo Finance • 22 days ago
Amgen vs. Iovance Biotherapeutics: Which Healthcare Stock Is a Better Buy in 2026?
Yahoo Finance • 26 days ago
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
About
CEO | Dr. Frederick G. Vogt Esq., J.D., Ph.D. |
Address | 825 Industrial Road, San Carlos, CA, United States, 94070 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 975 |